CH
Chimeric Therapeutics Limited
CHMMF · OTC
$0.10 +0.00% (+$0.00)
Market Cap $5.90M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.1
0.0% downside
Current Price
$0.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHMMF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 120.71%
ROA 1,470.94%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.12x
Debt/Equity N/A
Int. coverage N/A
Stability
69 /100
Stable Beta 0.74x
EPS volatility 25.32%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHMMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rebecca McQualter
Employees
5
Headquarters
Carlton
Upcoming events
26 FEB
Earnings
Upcoming earnings report